Translumina unveils dual-drug polymer-free coated stent in international markets
19 April 2022 | News
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
Image credit: https://translumina.com/in/
New Delhi-based Translumina has launched VIVO ISAR, its latest generation dual drug polymer-free coated stent (DDCS), in various international markets including Europe.
VIVO ISAR is the first Dual Drug Polymer-Free Coronary Stent technology, which brings together a stent with a superior safety profile without compromising the drug release kinetics.
VIVO ISAR is the first technology that uses Probucol, an antioxidant and lipid-lowering drug, as a carrier for releasing Sirolimus (an anti-restenotic drug) and thus creates a polymer-free DES platform with uncompromised safety and efficacy.
Translumina has launched VIVO ISAR in Italy & Spain and plans to roll it out in several markets across Europe, Latin America and APAC over the coming months.
